These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 4744597)

  • 41. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
    Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination chemotherapy of Hodgkin's disease.
    Nison DW; Aisenberg AC
    Cancer; 1974 Jun; 33(6):1499-504. PubMed ID: 4834147
    [No Abstract]   [Full Text] [Related]  

  • 43. Greater curability in advanced Hodgkin's disease?
    Portlock CS
    Cancer J Sci Am; 1999; 5(5):264-5. PubMed ID: 10526665
    [No Abstract]   [Full Text] [Related]  

  • 44. The treatment of Hodgkin's disease.
    Fairley GH
    Trans Med Soc Lond; 1972; 88():61-71. PubMed ID: 4665820
    [No Abstract]   [Full Text] [Related]  

  • 45. [Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)].
    Lauria F; Baccarani M; Barbieri E; Fiacchini M; Gobbi M; Tura S; Baccarani M
    Haematologica; 1975 Mar; 60(1):73-84. PubMed ID: 806500
    [No Abstract]   [Full Text] [Related]  

  • 46. Combined chemotherapy radiotherapy management of stage 3 Hodgkin's disease.
    Gamble JF; Fuller LM; Ibrahim E; Butler JJ; Shullenberger CC
    Arch Intern Med; 1973 Mar; 131(3):435-8. PubMed ID: 4688041
    [No Abstract]   [Full Text] [Related]  

  • 47. Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure.
    Campbell B; Wirth A; Milner A; Di Iulio J; MacManus M; Ryan G
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1538-45. PubMed ID: 16125872
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemotherapy as a primary treatment of Hodgkin's disease (204 new cases, 1 to 8 years of follow-up).
    Jacquillat C; Weil M; Auclerc G; Desprez-Curely JP; Chastang C; Garçon C; Chantalou JP; Gemon-Auclerc MF; Delobel J; Dana M; Tanzer J; Teillet F; Izrael V; Chelloul N; Weisgerber C; De Heaulme M; Boiron M; Bernard J
    Eur J Cancer (1965); 1975 Oct; 11(10):679-88. PubMed ID: 1204663
    [No Abstract]   [Full Text] [Related]  

  • 49. [Initial treatment of Hodgkin's disease with polychemotherapy. Long-term results in 226 cases (1- to 10-year follow-up)].
    Jacquillat Cl; Auclerc G; Weil M; Boiron M; Bernard J
    Sem Hop Ther; 1977 Apr; 53(4):213-6. PubMed ID: 882864
    [No Abstract]   [Full Text] [Related]  

  • 50. Hodgkin's disease; tracheoesophageal fistula during MOPP chemotherapy.
    Weiner MJ; Sicular A; Blaugrund SM; Sattler SM
    N Y State J Med; 1981 Sep; 81(10):1509-11. PubMed ID: 6944619
    [No Abstract]   [Full Text] [Related]  

  • 51. [Early results of combined treatment in Hodgkin's disease with nitrogen mustard, vincristine, Natulan and prednisone (MOPP treatment)].
    Zelechowska JA; Madej G; Piemkowska F
    Nowotwory; 1976; 26(3):163-70. PubMed ID: 980801
    [No Abstract]   [Full Text] [Related]  

  • 52. [Combined chemotherapy in Hodgkin's disease].
    Somers R; Haanen C; Hart AA; Kroese WF; Sizoo W; Wagener DJ
    Ned Tijdschr Geneeskd; 1976 Jun; 120(24):1038-43. PubMed ID: 1272447
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hodgkin's disease in children; treatment results with or without radiotherapy].
    Behrendt H
    Ned Tijdschr Geneeskd; 1986 May; 130(19):865-8. PubMed ID: 3754935
    [No Abstract]   [Full Text] [Related]  

  • 54. Skin infiltration in Hodgkin's disease.
    Gordon RA; Lookingbill DP; Abt AB
    Arch Dermatol; 1980 Sep; 116(9):1038-40. PubMed ID: 7416756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy of Hodgkin's disease. Maintenance therapy vs no maintenance after remission induction with combination chemotherapy.
    Luce JK; Frei E; Gehan EA; Coltman CA; Talley R; Monto RW
    Arch Intern Med; 1973 Mar; 131(3):391-5. PubMed ID: 4688037
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment of advanced Hodgkin's disease: 10-year experience in the Eastern Cooperative Oncology group.
    Glick JH; Barnes JM; Bakemeier RF; Prosnitz LR; Bennett JM; Neiman RS; Costello W; Orlow EL
    Cancer Treat Rep; 1982 Apr; 66(4):855-70. PubMed ID: 7042087
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The chemotherapeutic treatment of advanced Hodgkin's disease].
    Epelbaum R; Haim N; Ben-Shahar M; Valtuch I; Faraggi D; Sharabi-Nov A; Ben-Arie Y; Cohen Y
    Harefuah; 2001 Apr; 140(4):311-5, 367. PubMed ID: 11303395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Updated Hodgkin's disease. C. Advanced disease and special problems. Management with combination therapy.
    Rubin P
    JAMA; 1973 Jan; 223(2):164-6. PubMed ID: 4739455
    [No Abstract]   [Full Text] [Related]  

  • 59. [Recent progress in the treatment of Hodgkin's disease].
    Jacquillat C
    Acquis Med Recent; 1977; ():89-98. PubMed ID: 910606
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of Hodgkin's disease].
    Brule G
    Arq Patol; 1974; 46(2-3):273-7. PubMed ID: 4458640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.